General Information


DRACP ID  DRACP03818

Peptide Name  

Sequence  WWKAAAKAAAKWW

Sequence Length  13

UniProt ID  A0A0W8I9G3 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H108N20O14

Absent amino acids  CDEFGHILMNPQRSTVY

Common amino acids  A

Mass  178811

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  353

Hydrophobicity  -34.62

Aliphatic Index  46.15

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  22000

Absorbance 280nm  1833.33

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30897850

Title  Symmetrical Modification of Minimized Dermaseptins to Extend the Spectrum of Antimicrobials with Endotoxin Neutralization Potency

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12947

DRACP is developed by Dr.Zheng's team.